AXOGEN INC. - COMMON STOCK

NetDania - New 12 months High: AXOGEN INC. - COMMON STOCK

29 8 2024 07:41:24 提供 NetDania Notify

Axogen, Inc. Announces New Leadership Appointments

08 8 2024 04:05:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. Reports Second Quarter 2024 Financial Results

08 8 2024 04:00:01 提供 Nasdaq GlobeNewswire

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

23 7 2024 04:00:00 提供 Nasdaq GlobeNewswire

Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)

01 7 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™

24 6 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in Vandalia

28 5 2024 13:30:00 提供 Nasdaq GlobeNewswire

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

16 5 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads Conference

14 5 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc Reports First Quarter 2024 Financial Results

02 5 2024 04:00:01 提供 Nasdaq GlobeNewswire

Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™

29 4 2024 13:50:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

16 4 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results

05 3 2024 04:00:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024

13 2 2024 13:30:00 提供 Nasdaq GlobeNewswire

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

02 2 2024 13:15:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

18 1 2024 14:00:00 提供 Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

04 1 2024 13:45:00 提供 Nasdaq GlobeNewswire

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

04 1 2024 13:40:00 提供 Nasdaq GlobeNewswire

Axogen Announces Promotions on Research and Development Team

04 1 2024 13:35:00 提供 Nasdaq GlobeNewswire

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

26 12 2023 13:15:00 提供 Nasdaq GlobeNewswire